Endothelial Progenitor Cells in Coronary Artery Disease: From Bench to Bedside

Overview

Journal Stem Cells Transl Med

Publisher Oxford University Press

Specialties Cell Biology
Pharmacology

Date 2022 Apr 2

PMID 35365823

Authors

Francesco Pelliccia

Marco Zimarino

Giuseppe De Luca

Nicola Viceconte

Gaetano Tanzilli

Raffaele De Caterina

Affiliations

Soon will be listed here.

Abstract

Endothelial progenitor cells (EPCs) are a heterogeneous group of cells present in peripheral blood at various stages of endothelial differentiation. EPCs have been extensively investigated in patients with coronary artery disease (CAD), with controversial findings both on their role in atherosclerosis progression and in the process of neointimal growth after a percutaneous coronary intervention (PCI). Despite nearly 2 decades of experimental and clinical investigations, however, the significance of EPCs in clinical practice remains unclear and poorly understood. This review provides an update on the role of EPCs in the most common clinical scenarios that are experienced by cardiologists managing patients with CAD. We here summarize the main findings on the association of EPCs with cardiovascular risk factors, coronary atherosclerosis, and myocardial ischemia. We then discuss the potential effects of EPCs in post-PCI in-stent restenosis, as well as most recent findings with EPC-coated stents. Based on the mounting evidence of the relationship between levels of EPCs and several different adverse cardiovascular events, EPCs are emerging as novel predictive biomarkers of long-term outcomes in patients with CAD.

Citing Articles

Endothelial Homeostasis Under the Influence of Alcohol-Relevance to Atherosclerotic Cardiovascular Disease.

Gusti Y, Liu W, Athar F, Cahill P, Redmond E Nutrients. 2025; 17(5).

PMID: 40077672 PMC: 11901717. DOI: 10.3390/nu17050802.

Recent Insights into Endogenous Mammalian Cardiac Regeneration Post-Myocardial Infarction.

Fiorino E, Rossin D, Vanni R, Aubry M, Giachino C, Rastaldo R Int J Mol Sci. 2024; 25(21).

PMID: 39519298 PMC: 11546116. DOI: 10.3390/ijms252111747.

Biomechanical factors and atherosclerosis localization: insights and clinical applications.

Bacigalupi E, Pizzicannella J, Rigatelli G, Scorpiglione L, Foglietta M, Rende G Front Cardiovasc Med. 2024; 11:1392702.

PMID: 39119184 PMC: 11306036. DOI: 10.3389/fcvm.2024.1392702.

Responses of Endothelial Progenitor Cells to Chronic and Acute Physical Activity in Healthy Individuals.

Tkacz M, Zgutka K, Tomasiak P, Tarnowski M Int J Mol Sci. 2024; 25(11).

PMID: 38892272 PMC: 11173310. DOI: 10.3390/ijms25116085.

Isolation of circulating endothelial cells provides tool to determine endothelial cell senescence in blood samples.

Kalies K, Knopp K, Wurmbrand L, Korte L, Dutzmann J, Pilowski C Sci Rep. 2024; 14(1):4271.

PMID: 38383692 PMC: 10882010. DOI: 10.1038/s41598-024-54455-5.

References

De Maria G, Porto I, Burzotta F, Brancati M, Trani C, Pirozzolo G . Dual role of circulating endothelial progenitor cells in stent struts endothelialisation and neointimal regrowth: a substudy of the IN-PACT CORO trial. Cardiovasc Revasc Med. 2014; 16(1):20-6. DOI: 10.1016/j.carrev.2014.10.008. View

Saito S, Krucoff M, Nakamura S, Mehran R, Maehara A, Al-Khalidi H . Japan-United States of America Harmonized Assessment by Randomized Multicentre Study of OrbusNEich's Combo StEnt (Japan-USA HARMONEE) study: primary results of the pivotal registration study of combined endothelial progenitor cell capture and.... Eur Heart J. 2018; 39(26):2460-2468. PMC: 6037087. DOI: 10.1093/eurheartj/ehy275. View

Pelliccia F, Pasceri V, Moretti A, Tanzilli G, Speciale G, Gaudio C . Endothelial progenitor cells predict long-term outcome in patients with coronary artery disease: Ten-year follow-up of the PROCREATION extended study. Int J Cardiol. 2020; 318:123-125. DOI: 10.1016/j.ijcard.2020.06.002. View

Jaguszewski M, Aloysius R, Wang W, Bezerra H, Hill J, de Winter R . The REMEDEE-OCT Study: An Evaluation of the Bioengineered COMBO Dual-Therapy CD34 Antibody-Covered Sirolimus-Eluting Coronary Stent Compared With a Cobalt-Chromium Everolimus-Eluting Stent in Patients With Acute Coronary Syndromes: Insights From.... JACC Cardiovasc Interv. 2017; 10(5):489-499. DOI: 10.1016/j.jcin.2016.11.040. View

Sedaghat A, Sinning J, Paul K, Kirfel G, Nickenig G, Werner N . First in vitro and in vivo results of an anti-human CD133-antibody coated coronary stent in the porcine model. Clin Res Cardiol. 2013; 102(6):413-25. DOI: 10.1007/s00392-013-0547-4. View

Premer C, Schulman I . Predictive Value of Circulating Progenitor Cells in Acute Coronary Syndrome: Implications for Treatment. Circ Res. 2018; 122(11):1491-1493. PMC: 5978764. DOI: 10.1161/CIRCRESAHA.118.313032. View

Pelliccia F, Cianfrocca C, Rosano G, Mercuro G, Speciale G, Pasceri V . Role of endothelial progenitor cells in restenosis and progression of coronary atherosclerosis after percutaneous coronary intervention: a prospective study. JACC Cardiovasc Interv. 2010; 3(1):78-86. DOI: 10.1016/j.jcin.2009.10.020. View

Ripa R, Wang Y, Goetze J, Jorgensen E, Johnsen H, Tagil K . Circulating angiogenic cytokines and stem cells in patients with severe chronic ischemic heart disease--indicators of myocardial ischemic burden?. Int J Cardiol. 2006; 120(2):181-7. DOI: 10.1016/j.ijcard.2006.09.011. View

Ceradini D, Kulkarni A, Callaghan M, Tepper O, Bastidas N, Kleinman M . Progenitor cell trafficking is regulated by hypoxic gradients through HIF-1 induction of SDF-1. Nat Med. 2004; 10(8):858-64. DOI: 10.1038/nm1075. View

10.

Jakobsen L, Christiansen E, Freeman P, Kahlert J, Veien K, Maeng M . Randomized Clinical Comparison of the Dual-Therapy CD34 Antibody-Covered Sirolimus-Eluting Combo Stent With the Sirolimus-Eluting Orsiro Stent in Patients Treated With Percutaneous Coronary Intervention: The SORT OUT X Trial. Circulation. 2021; 143(22):2155-2165. DOI: 10.1161/CIRCULATIONAHA.120.052766. View

11.

Tahhan A, Hammadah M, Mohamed Kelli H, Kim J, Sandesara P, Alkhoder A . Circulating Progenitor Cells and Racial Differences. Circ Res. 2018; 123(4):467-476. PMC: 6202175. DOI: 10.1161/CIRCRESAHA.118.313282. View

12.

Fadini G, Mehta A, Dhindsa D, Bonora B, Sreejit G, Nagareddy P . Circulating stem cells and cardiovascular outcomes: from basic science to the clinic. Eur Heart J. 2020; 41(44):4271-4282. PMC: 7825095. DOI: 10.1093/eurheartj/ehz923. View

13.

Otto S, Nitsche K, Jung C, Kryvanos A, Zhylka A, Heitkamp K . Endothelial progenitor cells and plaque burden in stented coronary artery segments: an optical coherence tomography study six months after elective PCI. BMC Cardiovasc Disord. 2017; 17(1):103. PMC: 5405468. DOI: 10.1186/s12872-017-0534-1. View

14.

Wu J, Hsueh Y, Chang H, Luo C, Wu L, Nakauchi H . Circulating cells contribute to cardiomyocyte regeneration after injury. Circ Res. 2014; 116(4):633-41. DOI: 10.1161/CIRCRESAHA.116.304564. View

15.

Hill J, Zalos G, Halcox J, Schenke W, Waclawiw M, Quyyumi A . Circulating endothelial progenitor cells, vascular function, and cardiovascular risk. N Engl J Med. 2003; 348(7):593-600. DOI: 10.1056/NEJMoa022287. View

16.

Fadini G, De Kreutzenberg S, Albiero M, Coracina A, Pagnin E, Baesso I . Gender differences in endothelial progenitor cells and cardiovascular risk profile: the role of female estrogens. Arterioscler Thromb Vasc Biol. 2008; 28(5):997-1004. DOI: 10.1161/ATVBAHA.107.159558. View

17.

Klomp M, Beijk M, Varma C, Koolen J, Teiger E, Richardt G . 1-year outcome of TRIAS HR (TRI-stent adjudication study-high risk of restenosis) a multicenter, randomized trial comparing genous endothelial progenitor cell capturing stents with drug-eluting stents. JACC Cardiovasc Interv. 2011; 4(8):896-904. DOI: 10.1016/j.jcin.2011.05.011. View

18.

Montenegro F, Correia M, Muccillo F, Souza E Silva C, De Lorenzo A . Associations between endothelial progenitor cells, clinical characteristics and coronary restenosis in patients undergoing percutaneous coronary artery intervention. BMC Res Notes. 2018; 11(1):278. PMC: 5941758. DOI: 10.1186/s13104-018-3401-y. View

19.

Lee L, Chen C, Choong P, Low A, Tan H, Poh K . Time-dependent dynamic mobilization of circulating progenitor cells during percutaneous coronary intervention in diabetics. Int J Cardiol. 2009; 142(2):199-201. DOI: 10.1016/j.ijcard.2008.11.198. View

20.

Kuida K, Boucher D . Functions of MAP kinases: insights from gene-targeting studies. J Biochem. 2004; 135(6):653-6. DOI: 10.1093/jb/mvh078. View